Refine by
Cancer Diagnostics Articles & Analysis
9 articles found
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. ...
The development principle of cancer vaccines usually includes the identification of antigens, vaccine formulation, immune activation, and targeting of cancer cells. ...
CDH1 acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway, which is often dysregulated in cancer. What is the role of CDH1 in cancer? The loss or dysfunction of CDH1 has been implicated in the development and progression of various types of cancer. ...
Clarice Reid, a true leader and advocate for those affected by sickle cell disease and BioMark Diagnostics Inc. a diagnostic company focused in developing better cancer care management solutions. ...
The share price has fallen 12% to 220p Cancer diagnostics developer Oncimmune Holdings (LON: ONC) is delaying its 12-month results. ...
SubB2M is an engineered protein that specifically detects the pan-cancer biomarker Neu5Gc that is found at elevated levels in multiple human cancers. ...
The aim of the study is to validate a novel and minimally invasive liquid biopsy test for bladder cancer diagnosis using Nanostics’ ClarityDX® diagnostic platform. ...
I thought back to when my mom was sick, and wished we’d had a modern, more accurate MRD test available at that time for ovarian cancer. The Future of Cancer Diagnostics The diagnostics that we and others are developing measure the genome (an organism’s genes), proteome (proteins expressed by the genome) or the ...
Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI Combination of Exact Imaging’s micro-ultrasound and EDAP’s Focal ...